Rheumatoid Arthritis Associated Lung Complications
Abstract
Rheumatoid arthritis is the most common rheumatological disease worldwide with many articular and extra-articular complications, associated with comorbidities and mortality. Cardiac and pulmonary complications contribute the most towards morbidity, mortality and pose a great difficulty in the RA management. Many of the rheumatoid related lung complications can mimic other diseases such as infections and malignancies. Though the advancement in treatment of rheumatoid arthritis has improved many articular complications, but it has also increased risk of many pulmonary complications such as infections and drug related toxicities. Also, some of the very effective treatment options can’t be used in the presence of these rheumatoid related lung issues.
It’s important to understand these respiratory complications for the management of patients with rheumatoid arthritis which are seen by almost every doctor. The purpose of this review article is to provide insight into these pulmonary issues associated with rheumatoid arthritis and their management in the light of recent evidence.
How to Cite This Article
Hussain A, Avais J. Rheumatoid Arthritis Associated Lung Complications. J Pak Soc Intern Med. 2020;1(1):12–19. doi:10.70302/jpsim.v1i1.2006
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Bongartz T, Cantaert T, Atkins SR, et al. Citrullination in extra-articular manifestations of RA. Rheumatol (Oxford) 2007:46(1);70-5.
- Young A, Koduri G. Extra-articular manifestations and complications of RA. Best Pract Res Clin Rheumatol 2007: 21(5);907-27.
- Turesson C. Extra-articular rheumatoid arthritis. Curr Opin Rheumatol 2013: 25(3);360-6.
- Mielants H, Van Den Bosch F. Extra-articular manifestations. Clin Exp Rheumatol.2009:27(S55): S56-61.
- O'Dwyer DN, Armstrong ME, Cooke G. rheumatoid arthritis associated ILD. Eur J Intern Med.2013;24(7);597-603.
- Megan S, Bridget F, Lawrence A.Ho. Rheumatoid arthritis-associated lung disease. European Respiratory Review.2015:24(135);1-16.
- Marigliano B, Soriano A, Marriotta D. Lung involvement in connective tissues diseases: a comprehensive review and a focus on rheumatoid arthritis. Autoimmune Rev 2013; DOI: 10.1016/j.autrev.2013.05.001. doi:10.1016/j.autrev.2013.05.001
- Hill JA, Southwood S, Sette A. Cutting edge, conversion of arginine to citrulline allows for a high-affinity peptide interaction with rheumatoid arthritis associated HLA-DRB1 *0401 MHC class II molecule. J Immunol 2003;171(2):538-41.
- Klareskog L, Stolt P, Lundberg K. A new model for rheumatoid arthritis's aetiology: smoking may trigger HLA-DR (shared epitomes)-a restricted immune reaction to autoantigens modified by Citrullination. Arthritis Rheum 2006: DOI: 10.1002/art.21575. doi:10.1002/art.21575
- Rangel-Moreno J, Hartson L, Navaro C. Inducible bronchus-associated lymphoid tissue in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116(12):3183-94.
- Fischer A, Solomon JJ, du Bois RL. Lung disease with anti-CCP antibodies but no RA or connective tissue disease. Respir Med 2012;106(7):1040-7.
- Turesson C, McClelland RL, Christianson T, et al. Clustering of extra-articular manifestations in rheumatoid arthritis patients. J Rheumatol.2008: 35(1);179-180.
- Cavagna L, Monti S, Grosso V. The multifaceted aspects of interstitial lung disease in rheumatoid arthritis. Biomed Res Int. 2013; DOI: 10.1155/2013/759760. doi:10.1155/2013/759760
- Flaherty KR, Thwaite EL, Kazerooni EA. Radiological vs. histological diagnosis in UIP and NSIP: survival implications. Thorax 2003;58(2):143-8.
- Cottin V, Cordier JF. CPFE in connective tissue disease. Curr Opin Pulm Med 2012;18(5):418-27.
- Raghu G, Mageto YN, Lockhart D. Accuracy of clinical diagnosis of new onset IPF and other ILD: A perspective study. Chest. 1999;116(5):1168-74.
- Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of lung biopsy for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164(2):193-6.
- Gochuico BR, Avilla NA, Chow CK, et al. Progressive preclinical ILD in rheumatoid arthritis. Arch Intern Med 2008;168(2):159-66.
- Park JH, Kim DS, Park IN. Prognosis of fibrotic ILD: idiopathic vs. collagen vascular disease related subtypes. Am J Respir Crit Care Med. 2007;175(7);705-11.
- Fischer A, Brown KK, Du Bois RM, et al. Mycophenolate improves lung functions in connective tissue disease-associated ILD. J Rheumatol 2013; DOI: 10.3899/jrheum.121043. doi:10.3899/jrheum.121043
- Yazdani A, Singer LG, Strand V. Survival and quality of life in RA associated ILD after lung transplant. J Heart Lung Transplant 2014:33(5);514-20.
- Eunice JK, Harold RC, Talmadge EK. Rheumatoid arthritis -ILD: prevalence of histopathologic and radiographic pattern. Chest 2009: 136(5);1397-1405.
- Alpay KN, Celik S, Yilmaz OS. Cavitary pulmonary nodules in rheumatoid arthritis: case reports and review of the literature. Eur J Rheumatol 2018; DOI: 10.5152/eurjrheum.2017.16106. doi:10.5152/eurjrheum.2017.16106
- Zwirewich CV, Vedal S, Miller RR. Solitary pulmonary nodules: HRCT and radiologic-pathologic correlation. Radiology 1991:179(2);469-76.
- Gupta P, Ponzo F, Kramer EL. FDG uptake in pulmonary rheumatoid arthritis nodules. Clin Rheumatol 2005: 24(4);402-5.
- Chhakchhuak CL, Khosravi M, Lohr KM. Role of FDG-PET scan in rheumatoid arthritis lung nodules: case report and literature review. Rheumatol 2013; DOI: 10.1155/2013/621340. doi:10.1155/2013/621340
- Scheiber J, Koschel D, Kekow J. Rheumatoid pneumoconiosis. Eur J Intern Med 2010;21(3):168-72.
- Shahane A. Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis. Rheumatol Int 2013:33(7);1655-67.
- Dawson JK, Goodson NG. Raised pulmonary artery pressure with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology (Oxford). 2000;39(12):1320-25.
- Avnon LS, Abu-Shakra M, Flusser D. Pleural effusions in rheumatoid arthritis: what cell predominance to anticipate? Rheumatol Int 2007:27(10);919-25.
- Balbir-Gurman A, Yigla M, Nahir AM. Rheumatoid pleural effusions. Semin Arthritis Rheum 2006; 35(6): 368-78.
- Corcoran JP, Ahmad M, Mukherjee R. Pleuropulmonary complications of rheumatoid arthritis. Respir Care 2014:59(4): e55-9.
- Feraco P, Bazzocchi A, Righi S. Involvement of cricoarytenoid joints in rheumatoid arthritis. J Clin Rheumatol 2009;15(5):264.
- Mori S, Koga Y, Sugimoto M, et al. Small airway obstruction in rheumatoid arthritis. Mod Rheumatol 2011;21(2):164-173.
- Lynch JP, Weight SS, DerHovanessian A. Obliterative bronchiolitis. Semin Respir Crit Care Med 2012;33(5):509-32.
- Roubille S, Haraoui B. ILD induced or exacerbated by DMARDs and biologic agents in rheumatoid arthritis: a systematic review. Semin Arthritis Rheum 2014;43(5):613-26.
- Namba T, Tanaka KI, Ito Y. Induction of EMT-like phenotype by an active metabolite of leflunomide and its contribution to pulmonary fibrosis. Cell Death Differ 2010;17(12):1882-95.
- Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C. ILD induced or exacerbated by TNF inhibitors: analysis of 122 cases. Semin Arthritis Rheum 2011: 41(2);256-64.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.